跳至主要内容
临床试验/NCT06637917
NCT06637917
已完成
不适用

Pulse Oximetry Performance Comparison in Newborns

Medtronic - MITG3 个研究点 分布在 1 个国家目标入组 120 人2024年9月10日

概览

阶段
不适用
干预措施
OxySoftN™ Neonatal-Adult SpO2 Sensor with N600X Nellcor™ Patient Monitoring System
疾病 / 适应症
Newborn
发起方
Medtronic - MITG
入组人数
120
试验地点
3
主要终点
To compare time to stable signal of heart rate (HR) estimation between two pulse oximeters (PO).
状态
已完成
最后更新
上个月

概览

简要总结

The overall purpose is to directly compare pulse rate (PR) acquisition and oxygen saturation performance between two pulse oximeters (PO) in newborns.

注册库
clinicaltrials.gov
开始日期
2024年9月10日
结束日期
2025年9月18日
最后更新
上个月
研究类型
Observational
性别
All

研究者

责任方
Sponsor

入排标准

入选标准

  • Parent or legal guardian is willing and able to provide informed consent prior to any study procedures being performed.
  • Subject is expected to be able to participate for the duration of the evaluation in the delivery room. In most instances, the length of the study will not exceed the anticipated duration of ECG monitoring.
  • Subject is ≥ 29 weeks gestational age.
  • Subject can accommodate multiple sensors.

排除标准

  • Subjects that have an existing health condition, in which the investigator determines that safe or accurate oximetry measures may not be obtained at the areas where the PO sensor could be placed. For example, major congenital anomalies, limb anomalies or anyone with abrasions or surface lesions on the contact areas would be excluded.
  • Any subject whose treatment or condition would be compromised if they were to participate in this study and any patient whose use of a pulse oximeter and sensor would present a potential for serious risk to health, safety, or welfare.
  • Currently participating in any other study expected to confound study results in the opinion of the investigator.

研究组 & 干预措施

Newborn

A variety of subjects will be targeted for inclusion representing differing stages of development and environments

干预措施: OxySoftN™ Neonatal-Adult SpO2 Sensor with N600X Nellcor™ Patient Monitoring System

Newborn

A variety of subjects will be targeted for inclusion representing differing stages of development and environments

干预措施: LNCS® NEO SpO2 Sensor with RAD-97™ Pulse CO-Oximeter

Newborn

A variety of subjects will be targeted for inclusion representing differing stages of development and environments

干预措施: 1041PTS (or similar) Kendall™ Neonatal Electrodes with IntelliVue MP5 Portable Patient Monitor

结局指标

主要结局

To compare time to stable signal of heart rate (HR) estimation between two pulse oximeters (PO).

时间窗: Subject participation is expected to last a minimum of 5 minutes and a maximum of 12 hours.

To compare overall accuracy of heart rate (HR) estimation between two pulse oximeters (PO) as compared to gold standard electrocardiography (ECG).

时间窗: Subject participation is expected to last a minimum of 5 minutes and a maximum of 12 hours.

次要结局

  • To evaluate instances of false bradycardia.(Subject participation is expected to last a minimum of 5 minutes and a maximum of 12 hours.)
  • To evaluate instances of false bradycardia requiring emergency medical treatment.(Subject participation is expected to last a minimum of 5 minutes and a maximum of 12 hours.)
  • To evaluate variability in PR between the two PO sensors(Subject participation is expected to last a minimum of 5 minutes and a maximum of 12 hours.)
  • To compare the number of repositions and replacements required for the two PO sensors during monitoring.(Subject participation is expected to last a minimum of 5 minutes and a maximum of 12 hours.)

研究点 (3)

Loading locations...

相似试验